Voyager Therapeutics Inc (NASDAQ: VYGR) is 11.37% higher on its value in year-to-date trading and has touched a low of $6.06 and a high of $14.34 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VYGR stock was last observed hovering at around $10.35 in the last trading session, with the day’s loss setting it -0.95%.
Currently trading at $9.40, the stock is 3.21% and 14.67% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.08 million and changing -9.18% at the moment leaves the stock 8.80% off its SMA200. VYGR registered 20.82% gain for a year compared to 6-month loss of 22.16%. The firm has a 50-day simple moving average (SMA 50) of $1.20 and a 200-day simple moving average (SMA200) of $2.37.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 23.04% gain in the last 1 month and extending the period to 3 months gives it a 14.22%, and is 2.96% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.59% over the week and 7.62% over the month.
Voyager Therapeutics Inc (VYGR) has around 162 employees, a market worth around $510.42M and $250.01M in sales. Current P/E ratio is 3.04. Profit margin for the company is 52.93%. Distance from 52-week low is 55.12% and -34.45% from its 52-week high. The company has generated returns on investments over the last 12 months (52.22%).
Voyager Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -$0.45 with sales reaching $9.33M over the same period.The EPS is expected to shrink by -160.45% this year, but quarterly earnings will post -84.10% year-over-year. Quarterly sales are estimated to shrink -93.80% in year-over-year returns.
152 institutions hold shares in Voyager Therapeutics Inc (VYGR), with institutional investors hold 59.01% of the company’s shares. The shares outstanding are 44.04M, and float is at 42.78M with Short Float at 5.29%. Institutions hold 48.78% of the Float.
The top institutional shareholder in the company is EcoR1 Capital, LLC with over 3.85 million shares valued at $44.1 million. The investor’s holdings represent 8.77% of the VYGR Shares outstanding. As of Jun 29, 2023, the second largest holder is Armistice Capital, LLC with 3.62 million shares valued at $41.49 million to account for 8.26% of the shares outstanding. The other top investors are Blackrock Inc. which holds 2.48 million shares representing 5.64% and valued at over $28.37 million, while Vanguard Group Inc holds 5.64% of the shares totaling 2.48 million with a market value of $28.35 million.
Voyager Therapeutics Inc (VYGR) Insider Activity
The most recent transaction is an insider sale by Sandrock Alfred, the company’s President and CEO. SEC filings show that Sandrock Alfred sold 13,033 shares of the company’s common stock on Feb 21 ’24 at a price of $7.46 per share for a total of $97226.0. Following the sale, the insider now owns 0.33 million shares.
Voyager Therapeutics Inc disclosed in a document filed with the SEC on Feb 21 ’24 that Swartz Robin (Chief Operating Officer) sold a total of 3,966 shares of the company’s common stock. The trade occurred on Feb 21 ’24 and was made at $7.45 per share for $29547.0. Following the transaction, the insider now directly holds 0.12 million shares of the VYGR stock.
Still, SEC filings show that on Feb 21 ’24, PFREUNDSCHUH PETER P. (Chief Financial Officer) disposed off 3,764 shares at an average price of $7.46 for $28079.0. The insider now directly holds 175,669 shares of Voyager Therapeutics Inc (VYGR).
